ProPhase Labs Inc (PRPH)
5.16
+0.55
(+11.93%)
USD |
NASDAQ |
May 01, 16:00
5.15
-0.01
(-0.19%)
After-Hours: 20:00
ProPhase Labs Accounts Payable (Quarterly): 9.383M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.383M |
September 30, 2023 | 5.467M |
June 30, 2023 | 4.786M |
March 31, 2023 | 4.866M |
December 31, 2022 | 5.905M |
September 30, 2022 | 1.545M |
June 30, 2022 | 4.445M |
March 31, 2022 | 8.204M |
December 31, 2021 | 7.026M |
September 30, 2021 | 2.394M |
June 30, 2021 | 7.114M |
March 31, 2021 | 7.78M |
December 31, 2020 | 3.771M |
September 30, 2020 | 0.836M |
June 30, 2020 | 0.844M |
March 31, 2020 | 0.695M |
December 31, 2019 | 0.432M |
September 30, 2019 | 0.374M |
June 30, 2019 | 0.442M |
March 31, 2019 | 0.258M |
December 31, 2018 | 0.437M |
September 30, 2018 | 0.38M |
June 30, 2018 | 0.445M |
March 31, 2018 | 0.544M |
December 31, 2017 | 0.562M |
Date | Value |
---|---|
September 30, 2017 | 0.503M |
June 30, 2017 | 0.916M |
March 31, 2017 | 0.559M |
December 31, 2016 | 2.156M |
September 30, 2016 | 1.968M |
June 30, 2016 | 1.372M |
March 31, 2016 | 1.562M |
December 31, 2015 | 0.99M |
September 30, 2015 | 0.919M |
June 30, 2015 | 0.646M |
March 31, 2015 | 1.231M |
December 31, 2014 | 0.667M |
September 30, 2014 | 2.108M |
June 30, 2014 | 1.399M |
March 31, 2014 | 0.992M |
December 31, 2013 | 1.011M |
September 30, 2013 | 1.298M |
June 30, 2013 | 1.027M |
March 31, 2013 | 0.678M |
December 31, 2012 | 1.296M |
September 30, 2012 | 0.537M |
June 30, 2012 | 0.526M |
March 31, 2012 | 0.822M |
December 31, 2011 | 0.885M |
September 30, 2011 | 0.726M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.374M
Minimum
Sep 2019
9.383M
Maximum
Dec 2023
4.016M
Average
4.445M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Fonar Corp | 1.335M |
XWELL Inc | 1.099M |
Applied DNA Sciences Inc | 1.017M |
Veracyte Inc | 12.94M |
OncoCyte Corp | 0.953M |